Palantir stock trades flat as UK regulatory scrutiny targets NHS patient data access

Traders Union
All News
Financial News
Palantir slips 0.53% today to $135.39

Highlights

Palantir reported record quarterly revenue growth of 85% year-over-year to $1.63 billion, driven by strong AI platform demand across both commercial and government sectors.
Despite increased customer count and raised full-year revenue guidance to $7.64–$7.66 billion, the company faces regulatory scrutiny in the UK over NHS data access and mixed institutional investor activity.
Shares trade under sustained bearish pressure below key moving averages, with technical indicators signaling a likely further decline toward the $130–$140 price range barring an oversold rebound.

Record growth and UK scrutiny shape sentiment amid broad selling

Palantir reported its highest-ever quarterly revenue growth in Q1 2026, with revenue climbing 85% year-over-year to $1.63 billion and adjusted earnings per share at $0.33, demonstrating robust demand for its AI platform across both commercial and government sectors. The company raised full-year 2026 revenue guidance to $7.64–$7.66 billion, and also saw a 31% year-over-year increase in customer count. In the UK, Palantir attracted regulatory attention due to its involvement in the NHS National Data Integration Tenant platform, where staff were reportedly granted 'unlimited access' to identifiable patient data, while institutional investors adjusted positions in the last quarter, with NewEdge Wealth LLC increasing and Swiss Life Asset Management Ltd decreasing their stakes. These substantial business and regulatory developments have taken place, though price action has remained under broader selling pressure.

Limited downside as oversold signals counter neutral trend

The price remains below the SMA-20 at $141.36, SMA-50 at $145.66, and SMA-200 at $163.83. The Ichimoku Kijun line on the daily chart is positioned at $139.49, establishing immediate resistance. Momentum is weak and the MACD remains negative, while both daily and weekly ADX readings suggest a neutral to mild downtrend. The daily RSI is 44.01 and weekly RSI is 43.73, both indicating mild oversold conditions, with CCI at -100.96 also marking oversold territory. Stoch RSI stands at 16.70 and the BBP is at -2.23, both suggesting seller dominance and a continued oversold environment, with the Awesome Oscillator in negative territory. The current session opened with a slight gap up but now trades near the lower edge of the $134.88–$137.36 range amid moderate intraday volatility. Oscillator divergence across momentum and oversold readings implies that the downside may be limited for now, although sentiment has not convincingly shifted.

Further declines likely as breakout odds remain subdued

Over the next five sessions, typical volatility places the expected range for PLTR between $130 and $140. The probability of an upward break is low (less than 20%), favoring further declines. If the price rises above the $139.49 Kijun level, a short-term move toward $140 is possible. Weakness below $134.80 could trigger a slide toward $130. Unless oversold conditions prompt a bounce, the prevailing direction remains tilted to the downside.

Viktoras Karapetjanc, expert at Traders Union, sees Palantir’s record revenue growth and rising customer count as clear signals of robust business momentum. He believes the raised guidance and continued institutional activity reflect strong fundamental appeal, despite ongoing regulatory and sentiment headwinds. However, with price action subdued below major technical levels, near-term upside is limited unless oversold conditions spark a tactical bounce. "Palantir’s fundamentals remain impressive, and once seller pressure eases, I expect improved sentiment to drive a positive shift in the coming weeks."

Earlier, analysts noted that Palantir's robust financial performance continued to be overshadowed by persistent technical weakness and selling pressure. With ongoing oversold signals and regulatory developments now in focus, traders should closely monitor for a potential momentum shift near the $139.49 resistance, as a sustained failure to reclaim this level would keep downside risk at the forefront.

Source of Data: PLTR Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.